2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
CardioPROTECTion with Dapagliflozin in Breast Cancer Patients Treated with AnthrAcycline - PROTECTAA TRIALNeoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, cardiovascular disorder, heart disorder, heart failure, neoplasm, skin disorderRecruitingPhase 32024-12-04NCT06304857
The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA)Arrhythmias, Cardiac, Chemically-Induced Disorders, Chronic Pain, Drug-Related Side Effects and Adverse Reactions, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Muscle Hypotonia, Myotoxicity, Neurologic Manifestations, Neuromuscular Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Succinylcholine Sensitivity, Urogenital Diseases, acute kidney injury, butyrylcholinesterase deficiency, cardiovascular disorder, heart disorder, injury, kidney disorder, kidney failure, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, neuromuscular disease, radiation injury, urinary system disorderRecruitingNot applicable2024-11-27NCT06707532